Cardiovascular Systems, Inc. provided guidance for the fiscal year ending June 30, 2022. For the period, the company expects revenue to be between $235 million to $245 million and Net loss in a range of 15% to 18% of revenues.
Cardiovascular Systems, Inc.
Equities
CSII
US1416191062
Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | |
---|---|---|
-2.92% | 185B | |
-3.80% | 107B | |
-5.48% | 67.55B | |
+11.22% | 54.6B | |
+16.74% | 47.42B | |
+2.33% | 42.24B | |
+4.56% | 28.24B | |
+1.64% | 26.42B | |
+11.29% | 25.66B |